Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Christopher E. Barbieri, Sylvan C. Baca, Michael S. Lawrence, Francesca Demichelis, Mirjam Blattner, Jean Philippe Theurillat, Thomas A. White, Petar Stojanov, Eliezer Van Allen, Nicolas Stransky, Elizabeth Nickerson, Sung Suk Chae, Gunther Boysen, Daniel Auclair, Robert C. Onofrio, Kyung Park, Naoki Kitabayashi, Theresa Y. MacDonald, Karen Sheikh, Terry VuongCandace Guiducci, Kristian Cibulskis, Andrey Sivachenko, Scott L. Carter, Gordon Saksena, Douglas Voet, Wasay M. Hussain, Alex H. Ramos, Wendy Winckler, Michelle C. Redman, Kristin Ardlie, Ashutosh K. Tewari, Juan Miguel Mosquera, Niels Rupp, Peter J. Wild, Holger Moch, Colm Morrissey, Peter S. Nelson, Philip W. Kantoff, Stacey B. Gabriel, Todd R. Golub, Matthew Meyerson, Eric S. Lander, Gad Getz, Mark A. Rubin, Levi A. Garraway

Research output: Contribution to journalArticlepeer-review

1208 Scopus citations

Fingerprint

Dive into the research topics of 'Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences